Research finds air pollution may speed up Parkinson's Date 19 October 2020 Researchers in the US have uncovered a link between long-term exposure to pollution and deterioration in health conditions. This includes Parkinson's and Alzheimer's.
Oxford researchers find molecule that may slow or stop the progress of Parkinson's Date 29 September 2020 Parkinson's UK funded research suggests it may be possible to prevent the formation of protein clumps that cause problems in Parkinson's by using microscopic tweezers that pull apart the proteins. This could pave the way for a therapy that could slow or stop the progression of the condition.
Our campaigning priorities 2020-24 Date 28 September 2020 Sharing the results of the 'What Matters Most?' survey and coronavirus poll that have determined our campaigning priorities for the next four years
Our approach to starting in person activities Date 16 September 2020 Our in person events and activities have been on hold since March. We're taking a phased approach to starting them back up.
Trial results show statin drug does not slow Parkinson's Date 14 September 2020 Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.
Research shows bad dreams could predict future memory and thinking problems Date 14 August 2020 Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.
Link found between diabetes and increased Parkinson’s risk Date 11 August 2020 An international team of researchers have uncovered a biological link that may account for why those with diabetes have a higher risk of developing Parkinson’s.
Parkinson’s UK commit further funding to develop drugs that protect mitochondria Date 4 August 2020 We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Parkinson’s UK continues drug discovery with NRG Therapeutics Ltd. Date 3 August 2020 Parkinson's UK has invested an additional £1 million in NRG Therapeutics Ltd’s mitochondrial drug development programme.
How have coronavirus (COVID-19) restrictions impacted people affected by Parkinson’s? Date 2 July 2020 With Lancaster University, we conducted a survey that shows the coronavirus restrictions are having a big impact on the lives and the health of people affected by Parkinson’s.
